News
I f you're a FuturHealth member, you'll now have a free membership to Apple Fitness Plus as part of your program. It's Apple ...
8hon MSN
WeightWatchers’ stock reverses gains despite weight-loss-drug subscriptions boosting revenue
WW International, the company known as WeightWatchers, brought back its full-year outlook when it reported second-quarter ...
Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an ...
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
Researchers at Syracuse University have identified a brain peptide, TDN, that effectively curbs appetite and enhances glucose ...
Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...
Search trends reveal India’s wellness market shifting from home remedies to prescription weight-loss drugs, clinical ...
GLP-1 weight-loss drugs have already taken the Europe storm, altering consumer eating habits. Even the eating habits of GLP-1 ...
Scientists are looking into alternative weight loss solutions beyond GLP-1 medications like Mounjaro, Ozempic and Wegovy ...
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the National Pharmacy Association.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results